21256 ⎘
Medicinal preparations containing active ingredients not provided for in groups - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
COMBINATION
#3302METHODS OF TREATING NON-HODGKIN LYMPHOMA USING 2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE
#3303Antiviral Therapy
#3304CANCER TREATMENT USING LSD1 INHIBITORS AND PLK1 INHIBITORS
#3305MODULATORS OF KV3 CHANNELS TO TREAT PAIN
#3306METHOD OF TREATING CANCER WITH COMBINATIONS OF HISTONE DEACETYLASE INHIBITORS (HDACI) SUBSTANCES
#3307Use of short chain fatty acids for the treatment and prevention of diseases and disorders
#3308USE OF NADOLOL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOCKAGE OF THE ARRESTIN-2 PATHWAY
#3309STABLE CANNABINOID FORMULATIONS
#3310PHARMACEUTICAL COMPOSITIONS FOR USE IN REDUCING HYPERPIGMENTATION
#3311TOPICAL PEEL-OFF CREAM FOR NUMBING PAIN DURING SKIN-RELATED PROCEDURES
#3312COMPOSITIONS FOR CELL-BASED THERAPIES AND RELATED METHODS
#3313Membrane Encapsulated Nanoparticles and Method of Use
#3314CO-FORMULATION AND CO-DELIVERY OF IONIZABLE COLLOID FORMING DRUGS WITH NUCLEIC ACIDS
#3315Pharmaceutical Preparation for Topical Delivery of Botulinum Toxin
#3316METHODS FOR DEFINING STAGES AND PROGRESSION OF AMYOTROPHIC LATERAL SCLEROSIS
#3317TARGETED/IMMUNOMODULATORY FUSION PROTEINS AND METHODS FOR MAKING SAME
#3318Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof
#3319COMPOSITIONS AND METHODS FOR IMPLANTATION OF PROCESSED ADIPOSE TISSUE AND PROCESSED ADIPOSE TISSUE PRODUCTS
#3320DISRUPTING TUMOR TISSUES BY TARGETING FIBROBLAST ACTIVATION PROTEIN (FAP)
#3321TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT
#3322Anti-CD38 Antibodies for Treatment of Light Chain Amyloidosis and Other CD38-Positive Hematological Malignancies
#3323ANTIBODIES AGAINST CD14 AND USES THEREOF
#3324COMBINATIONS OF ANTI-INFLAMMATORY AGENTS FOR TREATING ACUTE ORGAN FAILURE, ARDS, ORGANS FOR TRANSPLANTATION OR DISEASES CAUSED BY AN AIRWAY-TARGETING VIRUS
#3325ANTI-IL36R ANTIBODIES
#3326Antibody Binding to Tie2 and Use Thereof
#3327CLEC12a Binding Polypeptides and Uses Thereof
#3328Safe and Effective Method of Treating Lupus with Anti-IL/IL23 Antibody
#3329TARGETING APOE ENHANCES T-CELL KILLING IN CANCER IMMUNOTHERAPY
#3330ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF
#3331IMMUNE CELLS DEFECTIVE FOR SUV39H1
#3332METHODS OF TREATING AGING-RELATED DISORDERS
#3333SURFACE LAYER PROTEIN A (SLPA) AS A THERAPEUTIC AGENT FOR THE TREATMENT OF INFLAMMATORY DISEASES
#3334THERAPEUTIC TREATMENT
#3335SOLID FORMS
#3336PSILOCYBIN AND O-ACETYLPSILOCIN, SALTS AND SOLID STATE FORMS THEREOF
#3337FUSED HETEROCYCLIC DERIVATIVES AND THEIR USE IN THE TREATMENT OF HBV INFECTION
#3338IRAK DEGRADERS AND USES THEREOF
#3339CBL-B INHIBITORS AND METHODS OF USE THEREOF
#3340CRYSTALLINE PHARMACEUTICAL AND METHODS OF PREPARATION AND USE THEREOF
#3341CRYSTALLINE FORM OF N-(2-CHLORO-3-((5-CHLORO-3-METHYL-4-OXO-3,4-DIHYDROQUINAZOLIN-6-YL)AMINO)-4-FLUOROPHENYL)-3-FLUOROAZETIDINE-1-SULFONAMIDE
#3342CYP11A1 INHIBITORS
#3343NANOPARTICLES FOR POTENTIATING EFFECTS OF RADIATION THERAPY ON ANTI-CANCER IMMUNOTHERAPY
#3344COMBINATION THERAPY FOR TREATING LUNG CANCER
#3345COMPOSITIONS FOR CHELATING METALS AT LOW TEMPERATURES
#3346OXAZAPHOSPHORINE ANTIBODY DRUG CONJUGATES AND METHODS OF USE
#3347DENDRIMER COMPOSITIONS AND METHODS FOR TREATMENT OF SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME
#3348CONJUGATES OF MONOCYCLIC BETA-LACTAMS AND SIDEROPHORE MIMETICS
#3349ANTI-CANCER VACCINE COMPOSITION COMPRISING PEPTIDES DERIVED FROM TUMOR-ASSOCIATED ANTIGEN, AND ADJUVANT CONSISTING OF LIPOPEPTIDE AND IMMUNOACTIVE SUBSTANCE, AND USE THEREOF
#3350METHODS FOR TREATING RESPIRATORY DISEASES
#3351SECRETED SPLICING VARIANT OF MAMMAL KLOTHO AS A MEDICAMENT FOR COGNITION AND BEHAVIOUR IMPAIRMENTS
#3352MATURATION OF MUCOSAL DEFENSE AND GUT/LUNG FUNCTION IN THE PRETERM INFANT
#3353COMPOSITIONS AND METHODS OF ALLEVIATING RESISTANCE TO CHEMOTHERAPY
#3354COMPOSITION FOR INHIBITING PROLIFERATION OF TUMOR COMPRISING SANGUISORBA OFFICINALIS EXTRACT AS EFFECTIVE COMPONENT
#3355COMBINATION OF SCUTELLARIA EXTRACTS WITH CITRUS BERGAMIA OR CYNARA CARDUNCULUS EXTRACTS AND FORMULATIONS CONTAINING THEM
#3356METHODS AND COMPOSITIONS FOR TREATING MUSCULOSKELETAL DISEASES
#3357BETA-GLUCAN IMMUNOTHERAPIES AFFECTING THE IMMUNE MICROENVIRONMENT
#3358Methods and Compositions for Treating Cancers and Enhancing Therapeutic Immunity by Selectively Reducing Immunomodulatory M2 Monocytes
#3359AGENTS ENCODING CLDN6 AND CD3 BINDING ELEMENTS FOR TREATING CLDN6-POSITIVE CANCERS
#3360KRAS ANTAGONISTS
#3361COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND VITAMIN B6
#3362Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
#3363Adhesive Oral Disc For Sustained Release Of Cannabinoids
#3364METHODS FOR EXTENDING LIFESPAN AND/OR DELAYING AGING
#3365COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR DISEASES AND INJURIES
#3366METHODS FOR TREATING IMMUNE REFRACTORY LUNG CANCER
#3367METHODS OF TREATING CANCERS USING STING AGONISTS
#3368COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
#3369ORAL PRODUCT
#3370IFENPRODIL SALTS AND THERAPEUTIC USES THEREOF
#3371WATER-SOLUBLE SALTS OF DNA BINDING AGENTS
#3372MANNOSE-DERIVED ANTAGONISTS OF FIMH USEFUL FOR TREATING DISEASE
#3373PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER
#3374PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS
#3375COMPOSITION CONTAINING ARTESUNATE
#3376METHODS AND COMPOSITIONS FOR TREATING INFECTION AND INFLAMMATION WITH SELENOCYANATE
#3377METHODS OF CANCER TREATMENT VIA REGULATED FERROPTOSIS
#3378DIALYSIS FLUID COMPRISING KETONE BODIES FOR THE TREATMENT OF CANCER
#3379NEUTROPHIL SUPPRESSION AS PRECONDITIONING TO INCREASE ONCOLYTIC BACTERIAL THERAPY
#3380CATIONIC LIPID-BASED NANOCARRIER AND PREPARATION METHOD AND APPLICATION THEREOF
#3381Mouthwash For Oral Care Benefits
#3382LIPID EMULSIONS FOR PARENTERAL NUTRITION
#3383COMPOSITIONS AND METHODS FOR TREATMENT OF MIC60 DEPLETED CANCERS AND METASTASIS
#3384CELL CULTURE PLATFORMS, METHODS AND USES THEREOF
#3385INHIBITOR OF TYPE 1 INTERFERON RECEPTOR STEROID SPARING IN SYSTEMIC LUPUS ERYTHERMATOSUS PATIENTS
#3386Camelid/Llama Nanobodies to Target WNT16B as a Chemotherapy Option for Cancer Treatment
#3387DELTA PROTOCADHERIN THERAPIES
#3388ANTIVIRAL COMPOUNDS
#3389IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION
#3390CYCLIC SULFONAMIDE RIBONUCLEOTIDE REDUCTASE (RNR) INHIBITORS AND USES THEREOF
#3391Lipid compound containing carbamate bond and applications thereof
#3392ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS
#3393COMPOSITIONS AND METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS
#3394AAV2-MEDIATED GENE DELIVERY OF SFASL AS A NEUROPROTECTIVE THERAPY IN GLAUCOMA
#3395NRAS GENE KNOCKOUT FOR TREATMENT OF CANCER
#3396NECTIN-4 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
#3397COMBINATION THERAPIES FOR THE TREATMENT OF CANCER
#3398PEPTIDES AND METHODS OF TRANSPLANTATION AND RESTORATIVE ORGAN FUNCTION
#3399TREATMENT OF GEOGRAPHIC ATROPHY
#3400TERLIPRESSIN COMPOSITIONS AND THEIR METHODS OF USE
#3401Composition for the prevention, improvement or treatment of allergic disease comprising an extract of Taxus cuspidata as an active ingredient
#3402Use of extracellular vesicles of Rhizoma Drynariae in preparation of medicine for treating orthopedic diseases
#3403METHODS OF POPULATING A GASTROINTESTINAL TRACT
#3404POLYMERS OBTAINED BY THE REACTION OF A PHENOLIC COMPOUND AND A CARBONYL COMPOUND FOR USE IN THE TREATMENT OR PREVENTION OF A CONDITION ASSOCIATED WITH ONE OR MORE PROTEASE(S)
#3405METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS
#3406COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND NATURAL COMPOUNDS FOR THE PROMOTION OF HEALTHY BRAIN AGING
#3407METHODS OF TREATING OCULAR CONDITIONS
#3408CRYSTALLINE FORMS OF N-((1R,3S)-3-(4-ACETYLPIPERAZIN-1-YL)CYCLOHEXYL)-4-FLUORO-7-METHYL-1H-INDOLE-2-CARBOXAMIDE
#3409COMBINATION OF A PD-1 ANTAGONIST AND A VEGF-R/FGFR/RET TYROSINE KINASE INHIBITOR FOR TREATING CANCER
#3410Fatty acid compositions
#3411DEUTERATED ANALOGS OF D-SERINE AND USES THEREOF
#3412NEW SYNERGISTIC COMBINATIONS BASED ON FENM AND AN ACETYLCHOLINESTERASE INHIBITOR
#3413Methods of Treating Mitochondrial Dysfunction
#3414OROMUCOSAL NANOFIBER CARRIERS FOR THERAPEUTIC TREATMENT
#3415METHODS RELATED TO MEGAKARYOCYTE-DERIVED EXTRACELLULAR VESICLES
#3416METHODS FOR MAGNETIC RESONANCE IMAGING OF NANOCONSTRUCTS AND USES THEREOF
#3417GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS
#3418COMPOSITIONS AND METHODS FOR DETECTING AND TREATMENT OF MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
#3419METHODS OF SELECTING AND TREATING CANCER SUBJECTS THAT ARE CANDIDATES FOR TREATMENT USING INHIBITORS OF PARP
#3420PHARMACEUTICAL COMBINATIONS FOR TREATMENT OF HBV
#3421Trispecific T cell Engagers
#3422COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH
#3423COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING DISEASE ASSOCIATED WITH AVB8 INTEGRIN
#3424ANTI-PD-1 ANTIBODY AND USE THEREOF
#3425CYTOTOXICITY-INDUCING THERAPEUTIC AGENT FOR USE IN TREATMENT OF CANCER
#3426ANTI-TMEFF1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES
#3427METHODS OF TREATMENT OF DISEASES IN WHICH IL-13 ACTIVITY IS DETRIMENTAL USING ANTI-IL-13 ANTIBODIES
#3428Anti-IL-33 Antibodies and Uses Thereof
#3429COMPOSITIONS AND METHODS THAT INHIBIT IL-23 SIGNALING
#3430ANTIBODY MOLECULES TO DENGUE VIRUS AND USES THEREOF
#3431PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
#3432CYCLIC DEOXYRIBONUCLEOTIDE COMPOUNDS
#3433BCL-2 INHIBITORS
#3434SALTS, CRYSTAL FORMS, AND PRODUCTION METHODS THEREOF
#3435ALSTONINE DERIVATIVES AND SALTS THEREOF
#3436NOVEL DEUTERATED JAK INHIBITOR AND USES THEREOF
#3437Cbl-b Inhibitors and Methods of Use Thereof
#3438SULFAMIDE RIBONUCLEOTIDE REDUCTASE (RNR) INHIBITORS AND USES THEREOF
#3439ISOINDOLINES AS PMS2 INHIBITORS
#3440ISOLATED TRANS ISOMER OF 3-(2-BROMO-3,4-DIHYDROXY-PHENYL)-N-(3,4,5-TRIHYDROXY-BENZYL)-THIOACRYLAMIDE
#3441Methods for making and using endoxifen
#3442SWALLOWABLE DRUG DELIVERY DEVICE AND METHODS OF DRUG DELIVERY
#3443CONJUGATES, COMPOSITIONS, AND METHODS FOR HYDROXYAPATITE-TARGETED IMAGING AND THERAPY
#3444mRNA THERAPY WITH REDUCED IMMUNE REACTOGENICITY
#3445BERBERIS COMPOSITION FOR COGNITIVE HEALTH
#3446PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE PREVENTION OR TREATMENT OF VIRAL INFECTIONS
#3447COMPOSITION COMPRISING PASTEURIZED AKKERMANSIA FOR THE TREATMENT OR PREVENTION OF IBS-RELATED ANXIETY
#3448PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES
#3449SHP1 MODIFIED DENDRITIC CELLS AND EXTRACELLULAR VESICLES DERIVED THEREFROM AND ASSOCIATED METHODS
#3450BUFFERING FOR NON-ALCOHOLIC STEATOHEPATITIS AND LIVER DISEASES
#3451MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING
#3452Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
#3453C-KIT INHIBITORS AND USES FOR TREATING AND PREVENTING INFLAMMATORY CONDITIONS
#3454Improvement of Tumor Immunogenicity by Means of Splicing-Controlling Compound
#3455TREATMENT OR PREVENTION OF NEW-ONSET TYPE 1 DIABETES WITH BARICITINIB
#3456METHODS OF PREVENTING A VENOUS THROMBOEMBOLIC EVENT
#3457TREATMENT OF CHRONIC COUGH, BREATHLESSNESS AND DYSPNEA
#3458Tamper Resistant Immediate Release Formulations
#3459SULFASALAZINE SALTS, PRODUCTION PROCESSES AND USES
#3460COMPOSITIONS IN THE FORM OF A UREA POWDER
#3461STABLE AQUEOUS CAPSAICIN INJECTABLE FORMULATIONS AND MEDICAL USES THEREOF
#3462EFFECT OF GLYCEROL ON BIOFILM FORMING BACTERIA AND FUNGI THAT CHANGES THE MICROBES SENSITIVITY TO PRO AND ANTI-BIOFILM NON-TOXIC, NON-BONDED PLASMA AMINO ACIDS AND AMINO ACID DERIVATIVES
#3463EXTRACELLULAR VESICLES FROM MICROALGAE, THEIR BIODISTRIBUTION UPON ADMINISTRATION, AND USES
#3464USE OF NANOPARTICLES FOR THE TREATMENT OF FISTULIZING ANOPERINEAL LESIONS
#3465TREATMENT USING THERMOSENSITIVE LIPOSOMES
#3466Improved Nasal Administration of Parkinson's Therapeutics
#3467RNA REPLICON FOR IMPROVING GENE EXPRESSION AND USE THEREOF
#3468COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY
#3469MONOCLONAL ANTIBODY AND A METHOD THEREOF
#3470NMN And Derivatives For Its Use In The Treatment Of Depression And/Or Anxiety In Patients Having A Form Of Parkinsonism
#3471COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS
#3472SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT
#3473CRYSTALLINE FORMS OF N-[4-[4-(4-MORPHOLINYL)-7H-PYRROLO[2,3-d]PYRIMIDIN-6-YL]PHENYL]-4-[[3(R)-[(1-OXO-2-PROPEN-1-YL)AMINO]-1-PIPERIDINYL]METHYL]-2-PYRIDINECARBOXAMIDE AS IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTION
#3474TETRAHYDRONAPTHYRIDINE AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD
#3475G-PROTEIN-COUPLED RECEPTOR REGULATORS AND METHODS OF USE THEREOF
#3476COMPOUNDS, COMPOSITIONS, AND METHODS FOR SELECTIVELY INHIBITING ß-GLUCURONIDASES AND ALLEVIATING SIDE EFFECTS ASSOCIATED WITH DRUG TREATMENT INDUCED DIARRHEA
#3477Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease
#3478MODULATION OF NEURONAL NKCC1 AS A THERAPEUTIC STRATEGY FOR SPASTICITY AND RELATED DISORDERS
#3479GENE THERAPY WITH THE GENES HOKD AND LDRB FOR CANCER TREATMENT
#3480COMBINATION THERAPY FOR TREATMENT OF CORONARY ARTERY DISEASE
#3481COMPOSITIONS AND METHODS FOR ENHANCING EFFICACY AND REDUCING ADVERSE EFFECTS FROM COVID VACCINATION
#3482COMPOSITIONS AND METHODS FOR IMMUNE HEALTH
#3483USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
#3484ANTIMICROBIAL COMPOSITIONS
#3485MITOCHONDRIAL AUGMENTATION THERAPY WITH STEM CELLS ENRICHED WITH FUNCTIONAL MITOCHONDRIA
#3486MOLECULES THAT BIND TO CD276 POLYPEPTIDES
#3487OPHTHALMIC FORMULATIONS FOR TREATMENT OF PRESBYOPIA, DRY EYE DISEASE AND COMPUTER VISION SYNDROME
#3488METHODS FOR TREATING ALZHEIMER’S DISEASE
#3489BETA-LACTAMASE INHIBITORS AND USES THEREOF
#3490Compositions of Iboga Alkaloids and Methods of Treatment
#3491Methods of Treatment With an Iboga Alkaloid
#3492SMALL MOLECULE TRAIL GENE INDUCTION BY NORMAL AND TUMOR CELLS AS AN ANTICANCER THERAPY
#3493USE OF TREM-1 INHIBITORS FOR TREATMENT, ELIMINATION AND ERADICATION OF HIV-1 INFECTION
#3494COMPOSITION COMPRISING TWO ENZYME INHIBITORS TARGETING TWO DIFFERENT CONFORMATIONS OF AN ENZYME
#3495COMPOSITION AND METHODS OF USE OF NOVEL PHENYLALANINE SMALL ORGANIC COMPOUNDS TO DIRECTLY MODULATE PCSK9 PROTEIN ACTIVITY
#3496NICOTINE LOZENGE
#3497USES OF A LYSYL OXIDASE-LIKE 2 INHIBITOR
#3498COMPOSITIONS, SYSTEMS AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND LOSARTAN
#3499COMPOSITIONS, SYSTEMS AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND CALCIUM CHANNEL BLOCKERS
#3500COMPOSITIONS, SYSTEMS AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND ANTI-FIBROTIC AGENTS THAT ARE NON-TUMORIGENIC
#3501COMBINATION THERAPY FOR THE TREATMENT OF GASTROINTESTINAL STROMAL TUMORS
#3502METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
#3503Psychoactive alkaloid extraction and composition with inhibited dephosphorylation
#3504PHARMACEUTICAL COMBINATIONS
#3505METHODS OF TREATING PRADER-WILLI SYNDROME
#3506COMPOSITIONS AND METHODS OF TREATING INVASIVE PATHOGENS
#3507COMPOSITION FOR LIVING BODY
#3508Therapeutic methods and compositions for treating cancer using devimistat and a fatty acid oxidation inhibitor, a tyrosine kinase inhibitor, a glutaminase inhibitor, and/or a glycolysis inhibitor
#3509CYCLOBENZAPRINE FOR TREATMENT OR PREVENTION OF SEXUAL DYSFUNCTION ASSOCIATED WITH MENTAL HEALTH CONDITIONS IN FEMALE PATIENTS
#3510Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
#3511A METHOD FOR PREPARING A VETERINARY MEDICAMENT DOSAGE WITH INKS AND A VETERINARY MEDICAMENT DOSAGE OBTAINABLE BY THE METHOD
#3512Wound dressing
#3513A Drug-Eluting Stent Comprising a Biocompatible Thermoplastic Polymer Lining and a Drug- Containing Coating
#3514SYSTEMS AND METHODS FOR DETECTING ANXIETY USING EEG
#3515USE OF SOLUBLE TREM2 AS A NON-INVASIVE BIOMARKER FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH)
#3516FOXO1-TARGETED THERAPY FOR THE TREATMENT OF CANCER
#3517MUC5B-TARGETED ANTISENSE OLIGONUCLEOTIDES AND RELATED METHODS FOR MODULATING MUCIN EXPRESSION
#3518METHOD OF DIRECTED DIFFERENTIATION PRODUCING CORNEAL ENDOTHELIAL CELLS, COMPOSITIONS THEREOF, AND USES THEREOF
#3519MONOVALENT ASYMMETRIC TANDEM FAB BISPECIFIC ANTIBODIES
#3520Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof
#3521BISPECIFIC BINDING PROTEINS AGAINST ALARMINS AND USES THEREOF
#3522ANTI-CD8 ANTIBODIES AND USES THEREOF
#3523INHIBIN ANTIBODIES AND CANCER TREATMENT
#3524ANTIBODIES FOR USE AGAINST SARS-COV-2
#3525-ent-19-norprogesterone, compositions and uses thereof to treat traumatic brain injury (TBI), including concussions-
#3526CALICHEAMICIN DERIVATIVES AND ANTIBODY DRUG CONJUGATES THEREOF
#3527BENZOPIPERAZINE AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD
#3528CRYSTALLINE FORMS OF A BRUTON'S TYROSINE KINASE INHIBITOR
#3529NOVEL COMPOUNDS
#3530NK3 modulators and uses thereof
#3531SUBSTITUTED TRIAZOLOHETEROARYL COMPOUNDS AS USP1 INHIBITORS AND THE USE THEREOF
#3532BENZOXAZINONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS
#3533Methods of Manufacturing a Bifunctional Compound, Ultrapure Forms of the Bifunctional Compound, and Dosage Forms Comprising the Same
#3534PHENETHYLAMINE COMPOUNDS SALTS, POLYMORPHIC FORMS AND METHODS OF USE THEREOF
#3535METHODS FOR INHIBITING NATIVE AND PROMISCUOUS UPTAKE OF MONOAMINE NEUROTRANSMITTERS
#3536CRYSTALLINE TRYPTAMINE COMPOUNDS
#3537COMBINATION ELECTRICAL THERAPY WITH OTHER CANCER THERAPIES
#3538TREATMENT OF HEREDITARY ANGIOEDEMA WITH AAV GENE THERAPY VECTORS AND THERAPEUTIC FORMULATIONS
#3539METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING A CARTILAGE DAMAGE USING SOX9 GENE
#3540COMPOSITIONS AND METHODS FOR TREATING B-LYMPHOID MALIGNANCIES
#3541TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC) WITH TOLERIZING NANOPARTICLES
#3542BACTERIA USEFUL IN THE PREVENTION AND/OR TREATMENT OF RESPIRATORY PATHOLOGIES
#3543ASSOCIATION OF A FAECALIBACTERIUM PRAUSNITZII STRAIN AND ANTI-PD-1, ANTI-PD-L1 OR ANTI-CTLA-4 ANTIBODIES FOR THE TREATMENT OF CANCER
#3544AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE UROGENITAL SYSTEM
#3545ISOTONIC OR HYPERTONIC SALT-BASED COMPOSITIONS
#3546METHODS FOR INCREASING FAT ABSORPTION
#3547COMPOSITIONS AND METHODS FOR TREATING HEMIPLEGIC MIGRAINE
#3548METHOD FOR PREVENTING OR TREATING PULMONARY ARTERIAL HYPERTENSION BY USING 7-DEHYDROCHOLESTEROLS OR SALTS, OXIDES, METABOLITES, OR DERIVATIVES THEREOF
#3549COMPOSITIONS AND METHODS FOR TREATING EYES AND METHODS OF PREPARATION
#3550PEPTIDE AND SMALL MOLECULE AGONISTS OF EPHA AND THEIR USES
#3551USE OF LUVADAXISTAT FOR THE TREATMENT OF COGNITIVE IMPAIRMENT
#3552Helicase Primase Inhibitors For Treating Cancer In A Combination Therapy With Oncolytic Viruses
#3553Composition for preventing or treating cachexia and muscle loss
#3554DIHYDROMYRICETIN SPRAY-DRIED DISPERSION FORMULATIONS AND METHODS FOR FORMING THEM
#3555CANNABINOID PRODRUG COMPOUNDS
#3556SUBSTITUTED PHENYLALKYLAMINES
#3557A FILM-FORMING COMPOSITION COMPRISING PECTIN
#3558TAMPER RESISTANT DOSAGE FORMS
#3559DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES
#3560LIPOSOMAL COMPOSITIONS AND METHODS OF USE THEREOF FOR IMPROVED STABILITY, BIOAVAILABILITY & SUSTAINED RELEASE
#3561COMPOSITIONS, DEVICES AND METHODS FOR THE TREATMENT OF ALCOHOL USE DISORDER
#3562VECTOR FOR CANCER TREATMENT
#3563EXPLOITING IL33 SECRETION AS A THERAPEUTIC TARGET IN CANCER
#3564USES OF DLL3-TARGETING MULTISPECIFIC ANTIGEN-BINDING MOLECULES
#3565METHODS AND COMPOSITIONS FOR TARGETING TREG CELLS
#3566ANTI-CHEMOKIN LIKE RECEPTOR 1 ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS
#3567METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES
#3568MULTIFUNCTIONAL ANTIBODY-LIGAND TRAPS TO COUNTERACT IMMUNE TOLERANCE
#3569ANTIBODIES FOR SIGLEC-15 AND METHODS OF USE THEREOF TO TREAT DISUSE OSTEOPOROSIS
#3570CLAUDIN 4 AND CLAUDIN 9 ANTIBODIES AND METHODS OF TREATING CANCER
#3571USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA
#3572Anti-Sclerostin Antibodies and Their Use to Treat Bone Disorders as Part of a Regimen
#3573CONDITIONALLY ACTIVE PROTEINS FOR NEURODEGENERATIVE DISEASES
#3574MODIFIED ANTI-INFLAMMATORY PROTEINS AND METHOD OF USE
#3575POLYMERIC FORMS OF H-NOX PROTEINS
#3576MEANS AND METHODS FOR THE TREATMENT OF ANGIOGENESIS-, FIBROSIS- AND CANCER-RELATED DISEASES WITH PROTEIN OLIGOMERS COMPRISING NC-1-FC
#3577Nanoparticles Having Molecules That Bind or Block PD-L1 and Uses In Treating Cancer
#35784-AMINOPHENYLPHOSPHORYLCHOLINE COMPOUNDS FOR BLOCKING C-REACTIVE PROTEIN
#3579DIACYLGLYCEROL KINASE MODULATING COMPOUNDS
#3580Compounds, Compositions and Methods for Attenuation of Mammalian Translation of C-MYC or N-MYC Proteins of the MYC Proto-Oncogene Family of BHLH Transcription Factors
#3581SHORT-ACTING 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) ANALOGS INCORPORATING BENZOTHIAZOLE
#35821,2,4-Oxadiazole Derivatives as Immunomodulators
#3583Vaginal Drug Delivery Device
#3584Compositions and Methods for Treating Dopamine Disorders
#3585Compositions and Methods for Treating Dopamine Disorders
#3586DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY
#3587Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
#3588USE OF ANTI-CD40 ANTIBODY
#3589COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C-1 INHIBITOR
#3590METHODS FOR IMPROVING THE EFFICACY AND EXPANSION OF CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
#3591SECRETED SPLICING VARIANT OF MAMMAL KLOTHO AS A MEDICAMENT FOR COGNITION AND BEHAVIOUR IMPAIRMENTS
#3592PROPEPTIDE OF LYSYL OXIDASE FOR TREATMENT OF CANCER
#3593FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS
#3594COMPOSITIONS, KITS AND METHODS FOR TREATMENT OF COMPLEMENT-RELATED DISORDERS
#3595TUMOR AVATAR VACCINE COMPOSITIONS AND USES THEREOF
#3596PHARMACEUTICAL COMPOSITION FOR IMPROVING HEALTH, CURE ABNORMALITIES AND DEGENERATIVE DISEASE, ACHIEVE ANTI-AGING EFFECT OF THERAPY AND THERAPEUTIC EFFECT ON MAMMALS AND METHOD THEREOF
#3597COMPOSITIONS FOR MANAGEMENT OF HPV (HUMAN PAPILLOMA VIRUS) INFECTIONS
#3598NEGATIVELY CHARGED PARTICLES FOR THE TREATMENT OF INFLAMMATION-RELATED BURN INJURIES
#3599BLADDER PERFUSION PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#3600COMPOSITIONS COMPRISING SMALL MOLECULE REGULATORS OF TUMOR IMMUNITY AND METHODS OF USING SAME